New Survey Results from the American Society for Dermatologic Surgery Demonstrate Broad Scope of Practice for Dermatologic Surgeons

DermSurgery Associates From the American Society for Dermatological Surgery – American Society for Dermatologic Surgery infographic. New statistics released today

Local physician involved in clinical trials of Erivedge™ (Vismodegib), the First Medicine for Adults with Advanced Basal Cell Carcinoma | DermSurgery Associates

DermSurgery Associates Houston, TX – February 3, 2012 – Genentech announced that Erivedge ™ (vismodegib) capsule was approved by the

Important New Developments in actinic keratoses and basal cell carcinoma!

New treatments have been approved for for both actinic keratoses and basal cell carcinoma. From Skin and Allergy News: Actinic

2012

New Survey Results from the American Society for Dermatologic Surgery Demonstrate Broad Scope of Practice for Dermatologic Surgeons

Local physician involved in clinical trials of Erivedge™ (Vismodegib), the First Medicine for Adults with Advanced Basal Cell Carcinoma | DermSurgery Associates

Important New Developments in actinic keratoses and basal cell carcinoma!

Contact Us Today